大唐药业：呼和浩特市仁和房地产开发有限公司拟减持不超2%股份

Core Points - Datang Pharmaceutical announced that Hohhot Renhe Real Estate Development Co., Ltd. plans to reduce its holdings by up to 5,118,300 shares, representing 2% of the company's total share capital, within three months after 15 trading days from the announcement date [1] - The reason for the reduction is stated as operational development needs, with the shares being sourced from those acquired prior to the company's listing on the Beijing Stock Exchange [1] - This reduction will not lead to a change in the company's controlling shareholder or actual controller, nor will it adversely affect the company's production and operations [1] - The reduction price will be determined based on market prices, and there is uncertainty regarding the timing, quantity, and price of the reduction [1]